We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+7.42%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$14.1B
AUM Growth
+$2.17B
Cap. Flow
+$1.47B
Cap. Flow %
10.47%
Top 10 Hldgs %
18.97%
Holding
1,309
New
346
Increased
287
Reduced
265
Closed
392

Top Buys

Rank Stock Value
1
ZTS icon
Zoetis
ZTS
+$177M
2
LOW icon
Lowe's Companies
LOW
+$108M
3
STJ
St Jude Medical
STJ
+$95.4M
4
NWL icon
Newell Brands
NWL
+$88.6M
5
STZ icon
Constellation Brands
STZ
+$87.2M

Top Sells

Rank Stock Value
1
EMC
EMC CORPORATION
EMC
+$136M
2
UNH icon
UnitedHealth
UNH
+$99.3M
3
PYPL icon
PayPal
PYPL
+$85.4M
4
SBUX icon
Starbucks
SBUX
+$78.1M
5
CI icon
Cigna
CI
+$64.7M

Sector Composition

Rank Sector Weight
1 Healthcare 20.63%
2 Consumer Discretionary 12.48%
3 Communication Services 12.09%
4 Technology 9.72%
5 Industrials 9.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MON
26
DELISTED
Monsanto Co
MON
$101M 0.72%
985,365
+799,206
+429% +$83.8M
STJ
27
DELISTED
St Jude Medical
STJ
$94.2M 0.67%
+1,181,595
New +$95.4M
GCP
28
DELISTED
GCP Applied Technologies Inc.
GCP
$91.4M 0.65%
3,226,797
+285,249
+10% +$7.93M
ALLE icon
29
Allegion
ALLE
$13B
$89.8M 0.64%
1,303,189
+55,350
+4% +$3.9M
LUV icon
30
Southwest Airlines
LUV
$22.1B
$88.6M 0.63%
2,278,010
+891,763
+64% +$33.9M
MJN
31
DELISTED
Mead Johnson Nutrition Company
MJN
$87.4M 0.62%
1,105,791
+611,923
+124% +$52.2M
BCR
32
DELISTED
CR Bard Inc.
BCR
$86.2M 0.61%
384,419
+47,556
+14% +$10.7M
AMZN icon
33
Amazon
AMZN
$2.5T
$85.7M 0.61%
2,047,260
-656,460
-24% -$25.1M
LNKD
34
DELISTED
LinkedIn Corporation
LNKD
$85.6M 0.61%
447,673
+425,206
+1,893% +$81.5M
APD icon
35
Air Products & Chemicals
APD
$66.3B
$83.6M 0.59%
600,931
+578,859
+2,623% +$80.3M
C icon
36
Citigroup
C
$222B
$81.9M 0.58%
1,733,400
+1,042,422
+151% +$47.4M
BAX icon
37
Baxter International
BAX
$11.6B
$80.8M 0.57%
1,698,091
+1,623,879
+2,188% +$76.6M
DGX icon
38
Quest Diagnostics
DGX
$25.1B
$78.1M 0.56%
923,120
+327,519
+55% +$27.5M
MRK icon
39
Merck
MRK
$324B
$77.7M 0.55%
1,304,202
+1,235,647
+1,802% +$72.3M
INTU icon
40
Intuit
INTU
$81.1B
$76.1M 0.54%
691,600
+383,565
+125% +$42.9M
AXTA icon
41
Axalta
AXTA
$7.01B
$73.7M 0.52%
2,606,808
+1,481,048
+132% +$41.5M
AMD icon
42
Advanced Micro Devices
AMD
$851B
$72.2M 0.51%
10,445,224
+8,856,469
+557% +$56.5M
KLAC icon
43
KLA
KLAC
$275B
$72.1M 0.51%
10,337,760
+8,357,010
+422% +$60.2M
INCY icon
44
Incyte
INCY
$23.5B
$70.2M 0.5%
744,174
+106,511
+17% +$8.97M
PTC icon
45
PTC
PTC
$13.7B
$68.9M 0.49%
1,555,513
+98,722
+7% +$4.09M
GXP
46
DELISTED
Great Plains Energy Incorporated
GXP
$68.4M 0.49%
2,505,991
+2,465,017
+6,016% +$70.6M
TSE
47
DELISTED
Trinseo
TSE
$68.1M 0.48%
1,204,591
+50,946
+4% +$2.7M
PYPL icon
48
PayPal
PYPL
$49.5B
$68.1M 0.48%
1,662,818
-2,220,750
-57% -$85.4M
XEC
49
DELISTED
CIMAREX ENERGY CO
XEC
$66.8M 0.48%
497,252
+241,496
+94% +$30.3M
MDT icon
50
Medtronic
MDT
$107B
$66.6M 0.47%
770,619
-358,738
-32% -$31.3M
1
2
3 4 5

Similar funds

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $94.5B AUM 29.33% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

Marshall Wace's Q3 2016 Portfolio in Review

As of Q3 2016, Marshall Wace held 1,309 positions worth $14.1B, up 18% from $11.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Marshall Wace deployed $1.47B of net new capital in Q3 2016, opening 346 new positions and adding to 287 existing holdings. Its largest new stake was St Jude Medical: 1,181,595 shares worth $94.2M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was UnitedHealth, an estimated $99.3M trimmed.

  • Marshall Wace's largest Q3 2016 buy was St Jude Medical: 1,181,595 shares worth $94.2M.
  • Marshall Wace added most to Zoetis in Q3 2016, an estimated $177M increase.
  • Marshall Wace's biggest Q3 2016 reduction was UnitedHealth, cutting an estimated $99.3M.
  • Marshall Wace fully exited EMC CORPORATION in Q3 2016, selling an estimated $136M.
  • Marshall Wace's ten largest holdings make up 19% of its $14.1B portfolio in Q3 2016.
  • Marshall Wace opened 346 new positions and closed 392 in Q3 2016.
  • Marshall Wace's portfolio value rose 18% quarter-over-quarter to $14.1B.

Based on Marshall Wace's 13F filing for Q3 2016, filed 10 Nov 2016.